Why the study?
A potential danger of antihypertensive drugs regarding cancer susceptibility has generated major debate in the scientific community and concern in the public.
Do antihypertensive drugs increase the risk of developing different neoplasms?
Do antihypertensive drugs increase the risk of developing different neoplasms?
This review highlights the need for newly developed approaches to generate more accurate recommendations regarding the potential cancer risk associated with antihypertensive drugs.
Answers are grounded in this paper and cite their sources.
Existing data on antihypertensive cancer risks warrant cautious clinical interpretation; leaves open need for improved methodologies to refine recommendations.
: The issue of a potential danger of antihypertensive drugs related to cancer susceptibility is currently generating a major debate in the scientific community, concerns in the public and emphasized interest from the media. The present article is a thorough review of what is known on the various classes of antihypertensive drugs concerning the risk of developing different neoplasms and about the suggested pathophysiological mechanisms, whenever available. The main limitations of evidence derived from studies currently available in this setting are also discussed, high-lightening the need for newly developed approaches to generate more accurate recommendations and informed advice for physicians.
No takes yet. Share an insight, caveat, or question.
Battistoni et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: